comparemela.com
Home
Live Updates
Sam Slutsky - Breaking News
Pages:
Latest Breaking News On - Sam slutsky - Page 2 : comparemela.com
Rain Therapeutics Inc (NASDAQ:RAIN) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Rain Oncology, Inc. First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
United states
Joe catanzaro
Tony butler
Sam slutsky
Mitchell kapoor
Yigal nochomovitz
Nelson cabatuan
Richard bryce
Graig suvannavejh
Robert doebele
Michael schmidt
Faisal khurshid
Bob doebele
Piper sandler
Jeff jones
Avantika joshi
InflaRx (IFRX) Gets a Buy from SVB Securities
In a report released on April 4, Joseph Schwartz from SVB Securities reiterated a Buy rating on InflaRx (IFRX – Research Report), with a p.
Sam slutsky
Renfeng guo
Niels christoph riedemann
Joseph schwartz
Nicolas fulpius
Credit suisse
Research report
Sarepta therapeutics
Biomarin pharmaceutical
Lifesci capital
InflaRx (IFRX) was upgraded to a Buy Rating at LifeSci Capital
InflaRx (IFRX – Research Report) received a Buy rating and price target from LifeSci Capital analyst Sam Slutsky today. The company̵.
Sam slutsky
Renfeng guo
Niels christoph riedemann
Nicolas fulpius
Research report
Lifesci capital
Brain therapeutics
Cogent biosciences
Strong buy
Ventyx Biosciences, Inc (VTYX) Q3 2022 Earnings Call Transcript
Ventyx Biosciences, Inc. (NASDAQ:NASDAQ:VTYX) Q3 2022 Earnings Conference Call November 03, 2022 04:30 PM ET Company Participants Marty Auster - Chief Financial Officer Raju Mohan - Founder.
Raju mohan
Piper sandler
Marty auster
Swapnil malekar
Jeff jones
Emily bodnar
Sam slutsky
Alex thompson
Company participants
Ventyx biosciences inc
Ventyx biosciences
Conference call november
Chief executive
Chief medical
Ventyx biosciences third quarter
Chief financial
vimarsana © 2020. All Rights Reserved.